Evidence map›Paper›PMID 36909318›Full record

ArticleFrontiers in endocrinology2023

Aspartate aminotransferase/alanine aminotransferase ratio was associated with type 2 diabetic peripheral neuropathy in a Chinese population: A cross-sectional study.

Pijun Yan, Yuru Wu, Xiaofang Dan, Xian Wu, Qian Tang, Xiping Chen, Yong Xu, Jianhua Zhu, Ying Miao, Qin Wan

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Pijun YanDepartment of Endocrinology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Yuru WuDepartment of Endocrinology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Xiaofang DanDepartment of Endocrinology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Xian WuDepartment of Endocrinology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Qian TangDepartment of Endocrinology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Xiping ChenSouthwest Medical University, Luzhou, China.
Yong XuDepartment of Endocrinology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Jianhua ZhuDepartment of Endocrinology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Ying MiaoDepartment of Endocrinology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Qin WanDepartment of Endocrinology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Despite previous research that focused on aspartate aminotransferase/alanine aminotransferase ratio (AAR) as predictors of type 2 diabetes mellitus (T2DM) and cardiovascular disease, there has been limited research evaluating the association between AAR and diabetic microvascular complications. This study aimed to investigate the association of AAR with diabetic peripheral neuropathy (DPN). Methods: A total of 1562 hospitalized patients with T2DM were divided into four groups according to AAR quartiles. The relationship between AAR and DPN and related parameters was explored by the Spearman correlation coefficients, multivariable logistic regression analysis, and receiver operating characteristic (ROC) curves. Results: Patients with higher AAR quartiles had higher levels of vibration perception threshold (VPT) and presence of DPN, and AAR was positively associated with VPT and presence of DPN independent of sex, age, body mass index, and diabetic duration (P<0.01 or P<0.05). Moreover, AAR remained significantly associated with a higher odds ratio (OR) of DPN (OR 2.413, 95% confidence interval [CI] 1.081-5.386, P<0.05) after multivariate adjustment. Additionally, the risk of presence of DPN increased progressively as AAR quartiles increased (all P for trend <0.01) in both male and female subjects, and the highest quartile of AAR of male and female subjects was respectively associated with 107.3% (95% CI: 1.386-3.101; P<0.01) and 136.8% (95% CI: 1.550-3.618; P<0.01) increased odds of DPN compared with the lower quartiles. Last, the analysis of receiver operating characteristic curves revealed that the best cutoff values for AAR to predict the presence of DPN were 0.906 (sensitivity: 70.3%; specificity: 49.2%; and area under the curve [AUC]: 0.618) and 1.402 (sensitivity: 38%; specificity: 81.9%; and AUC: 0.600) in male and female subjects, respectively. Conclusions: These findings suggest that the high AAR may be associated with the presence of DPN in Chinese patients with T2DM, and may be used as an additional indicator of risk of DPN.

Indexed as

Diabetes Mellitus, Type 2Diabetic NeuropathiesAlanine TransaminaseCross-Sectional StudiesEast Asian PeopleFemaleHumansMaleAlanine Transaminaseaspartate aminotransferase/alanine aminotransferase ratioChinese populationdiabetic peripheral neuropathytype 2 diabetes mellitusvibration perception threshold

Identifiers

PMID36909318
PMCPMC9998996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.